机构:[1]Department of Respiratory Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China内科科室呼吸内科昆明医科大学附属第一医院呼吸与危重症一科呼吸内科内科科室[2]Department of Respiratory Medicine, The People’s Hospital of Leshan, Leshan, China[3]Department of Thoracic Surgery, The Seventh People’s Hospital of Chengdu, Chengdu, China[4]Department of Geriatric Endocrinology, The First Affiliated Hospital of Kunming Medical University, Kunming, China内科科室干疗科内分泌科老年内分泌科昆明医科大学附属第一医院[5]Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院
Background: CRTC2 is highly expressed in lung cancer and contributes to lung cancer pathogenesis; however, whether CRTC2 promotes lung cancer metastasis remains unknown. In the present study, we investigated the role of CRTC2 in lung cancer metastasis in vitro. Methods: CRTC2 stable knockdown of lung cancer cell A549 was generated with small hairpin RNA and confirmed by quantitative reverse transcription-PCR and Western blot. Wound healing and invasion transwell assays were performed to explore migration and invasion activity, and Western blot was conducted to detect the expression of related proteins. Results: Suppression of CRTC2 significantly inhibited A549 cell migration and invasion in vitro. Mechanistic studies showed that knockdown of CRTC2 greatly downregulated MMP2 and MMP9 expression. CRTC2 silencing remarkably suppressed epithelial-mesenchymal transition by modulating the expression of E-cadherin and vimentin. Furthermore, suppression of CRTC2 expression significantly reduced MAPK/c-Jun N-terminal kinase activity. Conclusion: CRTC2 may promote A549 migration and invasion by modulation of c-Jun N-terminal kinase-mediated epithelial-mesenchymal transition and matrix metalloproteinase expression.
基金:
Department of Science and Technology of Yunnan Province [2017FE468 [-151], 2017FE468 [-200]]; Department of Education of Yunnan [2017zDX169, 2015Y182]
第一作者机构:[1]Department of Respiratory Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China
共同第一作者:
通讯作者:
通讯机构:[*1]Department of Respiratory Medicine, The First Affiliated Hospital of Kunming Medical University, No. 295th Xichang Road, Wuhua District, Kunming, Yunnan 650032, China[*2]Department of Geriatric Endocrinology, The First Affiliated Hospital of Kunming Medical University, No. 295th Xichang Road, Wuhua District, Kunming, Yunnan, 650032, China
推荐引用方式(GB/T 7714):
Shi Shaoqing,Luo Wei,Zhang Rui,et al.CRTC2 promotes non-small cell lung cancer A549 migration and invasion in vitro[J].THORACIC CANCER.2018,9(1):136-141.doi:10.1111/1759-7714.12550.
APA:
Shi, Shaoqing,Luo, Wei,Zhang, Rui,Wang, Chu,Zheng, Yuanyuan...&Luo, Zhuang.(2018).CRTC2 promotes non-small cell lung cancer A549 migration and invasion in vitro.THORACIC CANCER,9,(1)
MLA:
Shi, Shaoqing,et al."CRTC2 promotes non-small cell lung cancer A549 migration and invasion in vitro".THORACIC CANCER 9..1(2018):136-141